This trial is testing whether a shorter, more intense course of radiation therapy is as effective as the standard 3-week course for people with node positive breast cancer.
1 Primary · 9 Secondary · Reporting Duration: 1 and 3 years post randomization
Active Control
Experimental Treatment
588 Total Participants · 2 Treatment Groups
Primary Treatment: Locoregional radiation treatment - Hypofractionation · No Placebo Group · Phase 3
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: